Arca
Skip to content
Tools
Tools

SPY Laparoscope

Laparoscope, General & Plastic Surgery. 510(k) K252010, from Stryker Endoscopy (San Jose, CA). Product code GCJ, class 2.

As of Nov 18, 2026, K252010 is an FDA 510(k) held by Stryker Endoscopy, substantially equivalent on Jul 24, 2025 after 27 days, with no recalls tied to it in FDA's recall database.

  • Review time: 27 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

21 CFR 807.92(a)(5) The SPY Laparoscope is intended to be used for gynecological and general procedures that clinicians deem appropriate for the adult or pediatric patient aged one month or older, when the dimensions of the SPY Laparoscope are appropriate for the patient size and anatomy.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other GCJ clearances

The newest 510(k)s for the same product code; their median review was 128 days; see every GCJ device

Record

Type
Special
Received
Jun 27, 2025
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.1500

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.